DividendInvestor.com

First In Dividend Data Worldwide®

DIVIDEND ANNOUNCEMENT: Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) on 01/09/2023 declared a dividend of $0.2000 per share

January 09, 2023

Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) on 01/09/2023 declared a dividend of $ 0.2000 per share payable on March 15, 2023 to shareholders of record as of February 16, 2023. Dividend amount recorded is an increase of $ 0.01 from last dividend Paid.

Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) has paid dividends since 1970, has a current dividend yield of 2.0215280056% and has increased its dividends for 2 successive years.

Ord Cl A/Royalty Pharma plc's market cap is $ 16,801,651,360 and has a PE ratio of 33.41. The stock price closed yesterday at $ 38.09 and has a 52 week low/high of $ 36.15 and $ 44.75.

Royalty Pharma is a buyer of biopharmaceutical royalties. The royalties in Co.'s marketed portfolio related to approved products include: cystic fibrosis franchise, which consists of Co.'s right to receive royalty payments on the sale of various products for use in the treatment of cystic fibrosis, including Kalydeco (ivacaftor), Orkambi (lumacaftor and ivacaftor), Symdeko/Symkevi (tezacaftor and ivacaftor) and Trikafta/Kaftrio (elexacaftor, tezacaftor and ivacaftor); and Tysabri, which is a monoclonal antibody for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.

For more information on Ord Cl A/Royalty Pharma plc click here.

Ord Cl A/Royalty Pharma plc current dividend information as per the date of this press release is:
Dividend Declaration Date: January 09, 2023
Dividend Ex Date: February 15, 2023
Dividend Record Date: February 16, 2023
Dividend Payment Date: March 15, 2023
Dividend Amount: $ 0.2000
 
 

DividendInvestor.com

DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.

Contact:
info@DividendInvestor.com

X
Search Dividend Investor